Thursday - July 17, 2025
Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival
June 04, 2025
BALTIMORE, Maryland, June 4 (TNSjou) -- Johns Hopkins Medicine issued the following news release:

* * *

Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) -- the leading cause of cancer deaths worldwide -- improved long-term survival overall compared with chemotherapy alo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products